Ken Research Logo

Middle East pharma cold chain packaging market size, share, growth drivers, trends, opportunities & forecast 2025–2030

The Middle East pharma cold chain packaging market is valued at USD 1.3 billion, driven by rising demand for vaccines, biologics, and advanced packaging solutions in UAE and Saudi Arabia.

Region:Middle East

Author(s):Rebecca

Product Code:KRAC8439

Pages:95

Published On:November 2025

About the Report

Base Year 2024

Middle East Pharma Cold Chain Packaging Market Overview

  • The Middle East Pharma Cold Chain Packaging Market is valued at USD 1.3 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for temperature-sensitive pharmaceuticals, including vaccines and biologics, alongside the expansion of the healthcare sector in the region. The rising prevalence of chronic diseases, the growth of personalized medicine, and the need for effective drug distribution have further fueled the market's growth. The adoption of advanced insulated packaging and real-time temperature monitoring is also accelerating market development .
  • Countries such as the United Arab Emirates, Saudi Arabia, and Israel dominate the Middle East Pharma Cold Chain Packaging Market due to their advanced healthcare infrastructure, significant investments in pharmaceutical manufacturing, and strategic geographic locations that facilitate trade. These nations are also witnessing a surge in healthcare expenditure, which supports the demand for efficient cold chain solutions. Saudi Arabia and the UAE, in particular, are investing heavily in cold storage and supply chain innovation to support both pharmaceutical and biologics distribution .
  • In 2023, the UAE government implemented Cabinet Decision No. 32 of 2023 on the Regulation of Pharmaceutical Products and Medical Supplies, issued by the Ministry of Health and Prevention. This regulation mandates that all pharmaceutical products requiring refrigeration must be transported using certified cold chain logistics providers. The regulation sets operational standards for temperature monitoring, documentation, and compliance with international Good Distribution Practice (GDP) guidelines to ensure the integrity and efficacy of temperature-sensitive medications .
Middle East Pharma Cold Chain Packaging Market Size

Middle East Pharma Cold Chain Packaging Market Segmentation

By Type:The market is segmented into various types of packaging solutions that cater to the specific needs of temperature-sensitive pharmaceuticals. The key subsegments include Passive Packaging, Active Packaging, Refrigerated Containers, Insulated Shippers, and Others. Each type serves a unique purpose in maintaining the required temperature during transportation and storage.

Middle East Pharma Cold Chain Packaging Market segmentation by Type.

The Passive Packaging segment is currently leading the market due to its cost-effectiveness and ease of use. This type of packaging is widely adopted for transporting pharmaceuticals that do not require active temperature control but still need to be insulated against temperature fluctuations. The growing trend towards sustainability and the use of eco-friendly materials in passive packaging solutions are also contributing to its dominance .

By End-User:The market is segmented based on the end-users of cold chain packaging solutions, which include Pharmaceutical Manufacturers, Distributors, Hospitals and Clinics, Research Institutions, and Others. Each end-user has specific requirements for cold chain solutions based on the nature of their operations and the types of products they handle. Pharmaceutical manufacturers and distributors are the largest users due to the scale and sensitivity of their logistics needs .

Middle East Pharma Cold Chain Packaging Market segmentation by End-User.

Pharmaceutical Manufacturers dominate the market as they require reliable cold chain solutions to ensure the efficacy of their products during distribution. The increasing focus on biologics and vaccines, which are sensitive to temperature variations, has further solidified the position of manufacturers as the leading end-users in the cold chain packaging market .

Middle East Pharma Cold Chain Packaging Market Competitive Landscape

The Middle East Pharma Cold Chain Packaging Market is characterized by a dynamic mix of regional and international players. Leading participants such as DHL Supply Chain, Thermo Fisher Scientific, Envirotainer, Sonoco Products Company, Pelican BioThermal, Cold Chain Technologies, Cryopak, Packaging Technology Group, BioLife Solutions, AIT Worldwide Logistics, Inmark Packaging, A. J. Antunes & Co., Softbox Systems, Sealed Air Corporation, M. J. Maillis Group, TCDD Ta??mac?l?k A.?., Emirates SkyCargo, Gulf Cryo, Al Futtaim Logistics, Al Naboodah Logistics contribute to innovation, geographic expansion, and service delivery in this space.

DHL Supply Chain

1969

Bonn, Germany

Thermo Fisher Scientific

2006

Waltham, Massachusetts, USA

Envirotainer

1985

Stockholm, Sweden

Sonoco Products Company

1899

Hartsville, South Carolina, USA

Pelican BioThermal

2014

Plymouth, Minnesota, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate (YoY %)

Market Penetration Rate (Regional %)

Customer Retention Rate (Annual %)

Pricing Strategy (Premium, Value, or Economy)

Product Diversification Index (Number of Product Lines)

Middle East Pharma Cold Chain Packaging Market Industry Analysis

Growth Drivers

  • Increasing Demand for Temperature-Sensitive Pharmaceuticals:The Middle East has witnessed a surge in the demand for temperature-sensitive pharmaceuticals, driven by the rising prevalence of chronic diseases. In future, the region is expected to see a 15% increase in the consumption of biologics, which require strict temperature control during transportation. This growth is supported by the World Health Organization's report indicating that the biopharmaceutical market in the Middle East is projected to reach $10 billion by 2025, necessitating robust cold chain solutions.
  • Expansion of the Biopharmaceutical Sector:The biopharmaceutical sector in the Middle East is expanding rapidly, with investments reaching approximately $3 billion in future. This growth is fueled by government initiatives aimed at enhancing local production capabilities and reducing dependency on imports. The increasing number of biopharmaceutical companies, estimated at over 200 in the region, is driving the demand for advanced cold chain packaging solutions to ensure product integrity and compliance with stringent regulations.
  • Rising Healthcare Expenditure:Healthcare expenditure in the Middle East is projected to exceed $200 billion in future, reflecting a growing commitment to improving healthcare infrastructure. This increase is expected to enhance the distribution of temperature-sensitive medications, as hospitals and pharmacies invest in cold chain logistics. According to the International Monetary Fund, healthcare spending per capita in the region is anticipated to rise by 10% annually, further driving the need for efficient cold chain packaging solutions.

Market Challenges

  • High Operational Costs:The operational costs associated with cold chain logistics in the Middle East are significant, with estimates indicating that companies spend around $1.5 billion annually on temperature-controlled transportation. These costs are exacerbated by the need for specialized equipment and trained personnel, which can deter smaller companies from entering the market. The high costs can limit the accessibility of cold chain solutions, particularly in less developed regions of the Middle East.
  • Regulatory Compliance Complexities:Navigating the regulatory landscape for cold chain packaging in the Middle East presents challenges for companies. Compliance with various national regulations, which can differ significantly across countries, requires substantial resources. In future, it is estimated that companies will spend approximately $500 million on compliance-related activities, including audits and certifications, which can strain operational budgets and hinder market entry for new players.

Middle East Pharma Cold Chain Packaging Market Future Outlook

The future of the Middle East pharma cold chain packaging market appears promising, driven by technological advancements and increasing demand for temperature-sensitive products. The integration of IoT and AI technologies is expected to enhance monitoring and efficiency in cold chain logistics. Additionally, as healthcare expenditure continues to rise, the need for reliable cold chain solutions will become more critical, fostering innovation and investment in sustainable packaging practices that align with environmental regulations.

Market Opportunities

  • Growth in E-commerce for Pharmaceuticals:The e-commerce sector for pharmaceuticals is projected to grow significantly, with online sales expected to reach $5 billion in future. This growth presents an opportunity for cold chain packaging providers to develop tailored solutions that ensure the safe delivery of temperature-sensitive products directly to consumers, enhancing accessibility and convenience.
  • Development of Sustainable Packaging Solutions:There is a growing demand for sustainable packaging solutions in the pharmaceutical sector, with an estimated market value of $1 billion by future. Companies that invest in eco-friendly materials and practices can capitalize on this trend, appealing to environmentally conscious consumers and meeting regulatory requirements aimed at reducing packaging waste.

Scope of the Report

SegmentSub-Segments
By Type

Passive Packaging

Active Packaging

Refrigerated Containers

Insulated Shippers

Others

By End-User

Pharmaceutical Manufacturers

Distributors

Hospitals and Clinics

Research Institutions

Others

By Temperature Range

Controlled Room Temperature

Refrigerated Temperature

Frozen Temperature

Others

By Material Type

Plastic

Glass

Metal

Others

By Distribution Channel

Direct Sales

Online Sales

Distributors

Others

By Region

GCC Countries

Levant Region

North Africa

Others

By Application

Vaccines

Biologics

Clinical Trials

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Food and Drug Administration)

Pharmaceutical Manufacturers

Cold Chain Logistics Providers

Healthcare Providers and Hospitals

Pharmaceutical Distributors

Packaging Material Suppliers

Industry Associations (e.g., Middle East Pharmaceutical Association)

Players Mentioned in the Report:

DHL Supply Chain

Thermo Fisher Scientific

Envirotainer

Sonoco Products Company

Pelican BioThermal

Cold Chain Technologies

Cryopak

Packaging Technology Group

BioLife Solutions

AIT Worldwide Logistics

Inmark Packaging

A. J. Antunes & Co.

Softbox Systems

Sealed Air Corporation

M. J. Maillis Group

TCDD Tasmaclk A.S.

Emirates SkyCargo

Gulf Cryo

Al Futtaim Logistics

Al Naboodah Logistics

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Middle East Pharma Cold Chain Packaging Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Middle East Pharma Cold Chain Packaging Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Middle East Pharma Cold Chain Packaging Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for temperature-sensitive pharmaceuticals
3.1.2 Expansion of the biopharmaceutical sector
3.1.3 Rising healthcare expenditure
3.1.4 Technological advancements in packaging solutions

3.2 Market Challenges

3.2.1 High operational costs
3.2.2 Regulatory compliance complexities
3.2.3 Limited infrastructure in certain regions
3.2.4 Environmental concerns regarding packaging waste

3.3 Market Opportunities

3.3.1 Growth in e-commerce for pharmaceuticals
3.3.2 Development of sustainable packaging solutions
3.3.3 Increasing partnerships with logistics providers
3.3.4 Expansion into emerging markets

3.4 Market Trends

3.4.1 Adoption of IoT in cold chain monitoring
3.4.2 Shift towards eco-friendly packaging materials
3.4.3 Customization of packaging solutions
3.4.4 Integration of AI for supply chain optimization

3.5 Government Regulation

3.5.1 Compliance with WHO guidelines
3.5.2 National regulations on pharmaceutical storage
3.5.3 Environmental regulations on packaging waste
3.5.4 Import/export regulations for temperature-sensitive products

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Middle East Pharma Cold Chain Packaging Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Middle East Pharma Cold Chain Packaging Market Segmentation

8.1 By Type

8.1.1 Passive Packaging
8.1.2 Active Packaging
8.1.3 Refrigerated Containers
8.1.4 Insulated Shippers
8.1.5 Others

8.2 By End-User

8.2.1 Pharmaceutical Manufacturers
8.2.2 Distributors
8.2.3 Hospitals and Clinics
8.2.4 Research Institutions
8.2.5 Others

8.3 By Temperature Range

8.3.1 Controlled Room Temperature
8.3.2 Refrigerated Temperature
8.3.3 Frozen Temperature
8.3.4 Others

8.4 By Material Type

8.4.1 Plastic
8.4.2 Glass
8.4.3 Metal
8.4.4 Others

8.5 By Distribution Channel

8.5.1 Direct Sales
8.5.2 Online Sales
8.5.3 Distributors
8.5.4 Others

8.6 By Region

8.6.1 GCC Countries
8.6.2 Levant Region
8.6.3 North Africa
8.6.4 Others

8.7 By Application

8.7.1 Vaccines
8.7.2 Biologics
8.7.3 Clinical Trials
8.7.4 Others

9. Middle East Pharma Cold Chain Packaging Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate (YoY %)
9.2.4 Market Penetration Rate (Regional %)
9.2.5 Customer Retention Rate (Annual %)
9.2.6 Pricing Strategy (Premium, Value, or Economy)
9.2.7 Product Diversification Index (Number of Product Lines)
9.2.8 Supply Chain Efficiency (On-Time Delivery %)
9.2.9 Innovation Rate (New Product Launches per Year)
9.2.10 Brand Equity Score (Third-Party Brand Index)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 DHL Supply Chain
9.5.2 Thermo Fisher Scientific
9.5.3 Envirotainer
9.5.4 Sonoco Products Company
9.5.5 Pelican BioThermal
9.5.6 Cold Chain Technologies
9.5.7 Cryopak
9.5.8 Packaging Technology Group
9.5.9 BioLife Solutions
9.5.10 AIT Worldwide Logistics
9.5.11 Inmark Packaging
9.5.12 A. J. Antunes & Co.
9.5.13 Softbox Systems
9.5.14 Sealed Air Corporation
9.5.15 M. J. Maillis Group
9.5.16 TCDD Ta??mac?l?k A.?.
9.5.17 Emirates SkyCargo
9.5.18 Gulf Cryo
9.5.19 Al Futtaim Logistics
9.5.20 Al Naboodah Logistics

10. Middle East Pharma Cold Chain Packaging Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Government procurement policies
10.1.2 Budget allocation for pharmaceuticals
10.1.3 Supplier selection criteria
10.1.4 Contract management practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in cold chain infrastructure
10.2.2 Energy efficiency initiatives
10.2.3 Budgeting for technology upgrades
10.2.4 Partnerships with energy providers

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges in maintaining temperature control
10.3.2 Issues with packaging integrity
10.3.3 Delays in logistics and distribution
10.3.4 Compliance with regulatory standards

10.4 User Readiness for Adoption

10.4.1 Awareness of cold chain solutions
10.4.2 Training and skill development
10.4.3 Investment in technology
10.4.4 Feedback mechanisms for improvement

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of cost savings
10.5.2 Evaluation of service quality improvements
10.5.3 Expansion into new markets
10.5.4 Long-term sustainability assessments

11. Middle East Pharma Cold Chain Packaging Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps identification

1.2 Value proposition development

1.3 Revenue model exploration

1.4 Customer segmentation analysis

1.5 Competitive landscape overview

1.6 Key partnerships identification

1.7 Risk assessment


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs

2.3 Target audience identification

2.4 Communication strategies

2.5 Digital marketing initiatives

2.6 Trade show participation

2.7 Customer engagement tactics


3. Distribution Plan

3.1 Urban retail strategies

3.2 Rural NGO tie-ups

3.3 E-commerce integration

3.4 Logistics partnerships

3.5 Inventory management solutions

3.6 Distribution channel optimization

3.7 Performance metrics


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands analysis

4.3 Competitor pricing strategies

4.4 Customer willingness to pay

4.5 Value-based pricing models

4.6 Discount strategies

4.7 Price elasticity assessment


5. Unmet Demand & Latent Needs

5.1 Category gaps identification

5.2 Consumer segments analysis

5.3 Product development opportunities

5.4 Market entry barriers

5.5 Customer feedback incorporation

5.6 Future trends forecasting

5.7 Strategic recommendations


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service

6.3 Customer feedback mechanisms

6.4 Relationship management strategies

6.5 Engagement through social media

6.6 Personalization of services

6.7 Retention strategies


7. Value Proposition

7.1 Sustainability initiatives

7.2 Integrated supply chains

7.3 Cost-effectiveness

7.4 Quality assurance

7.5 Customer-centric approach

7.6 Innovation in packaging

7.7 Competitive differentiation


8. Key Activities

8.1 Regulatory compliance

8.2 Branding efforts

8.3 Distribution setup

8.4 Training and development

8.5 Market research

8.6 Stakeholder engagement

8.7 Performance monitoring


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix considerations
9.1.2 Pricing band analysis
9.1.3 Packaging requirements

9.2 Export Entry Strategy

9.2.1 Target countries selection
9.2.2 Compliance roadmap development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model

10.5 Risk assessment

10.6 Strategic fit evaluation

10.7 Long-term sustainability


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines for implementation

11.3 Funding sources

11.4 Financial projections

11.5 Risk management strategies

11.6 Milestone tracking

11.7 Contingency planning


12. Control vs Risk Trade-Off

12.1 Ownership considerations

12.2 Partnerships evaluation

12.3 Risk mitigation strategies

12.4 Control mechanisms

12.5 Long-term implications

12.6 Stakeholder alignment

12.7 Performance metrics


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability assessments

13.3 Profit margin projections

13.4 Cost management strategies

13.5 Revenue growth forecasts

13.6 Market share objectives

13.7 Financial health indicators


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition targets

14.4 Strategic alliances

14.5 Industry collaborations

14.6 Supplier partnerships

14.7 Research collaborations


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity tracking</

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from pharmaceutical associations and cold chain logistics publications
  • Review of government regulations and compliance standards related to pharmaceutical cold chain management
  • Examination of market trends and forecasts from reputable market research databases

Primary Research

  • Interviews with logistics managers at pharmaceutical companies to understand cold chain requirements
  • Surveys with cold chain packaging suppliers to gather insights on product offerings and innovations
  • Field interviews with regulatory experts to assess compliance challenges in the cold chain sector

Validation & Triangulation

  • Cross-validation of data through multiple sources including industry reports and expert interviews
  • Triangulation of findings from primary and secondary research to ensure data reliability
  • Sanity checks through expert panel reviews to validate market assumptions and projections

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on national pharmaceutical sales and cold chain logistics expenditure
  • Segmentation of the market by product type, temperature range, and end-user applications
  • Incorporation of growth rates from emerging markets and trends in biopharmaceuticals

Bottom-up Modeling

  • Collection of data on packaging volumes from leading cold chain packaging manufacturers
  • Operational cost analysis based on pricing models of cold chain logistics services
  • Volume x cost calculations to derive revenue estimates for different packaging solutions

Forecasting & Scenario Analysis

  • Multi-variable regression analysis incorporating factors such as healthcare spending and temperature-sensitive product growth
  • Scenario modeling based on potential regulatory changes and technological advancements in cold chain solutions
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Manufacturers100Supply Chain Managers, Quality Assurance Officers
Cold Chain Logistics Providers60Operations Directors, Logistics Coordinators
Regulatory Bodies40Compliance Officers, Regulatory Affairs Managers
Healthcare Institutions70Pharmacy Managers, Procurement Specialists
Cold Chain Packaging Suppliers50Product Development Managers, Sales Executives

Frequently Asked Questions

What is the current value of the Middle East Pharma Cold Chain Packaging Market?

The Middle East Pharma Cold Chain Packaging Market is valued at approximately USD 1.3 billion, driven by the increasing demand for temperature-sensitive pharmaceuticals, including vaccines and biologics, and the expansion of the healthcare sector in the region.

Which countries dominate the Middle East Pharma Cold Chain Packaging Market?

What are the key drivers of growth in the Middle East Pharma Cold Chain Packaging Market?

What types of packaging solutions are available in the Middle East Pharma Cold Chain Packaging Market?

Other Regional/Country Reports

Indonesia Pharma Cold Chain Packaging Market

Malaysia Pharma Cold Chain Packaging Market

KSA Pharma Cold Chain Packaging Market

APAC Pharma Cold Chain Packaging Market

SEA Pharma Cold Chain Packaging Market

Vietnam Pharma Cold Chain Packaging Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022